PATENT CLAIM ANALYSIS

Application Number: 15998847
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "211090"]

Abstract:
The present invention relates to medicine and includes a method for preventing and treating diseases caused by RNA- and DNA-containing viruses, and concomitant diseases, wherein the method comprises the use of an effective amount of compounds of general formula I or pharmaceutically acceptable salts thereof. The invention also relates to methods for preparing said compounds, pharmaceutical compositions for the prevention or treatment of diseases caused by RNA- and DNA-containing viruses, said compositions comprising an effective amount of a compound of formula I or a pharmaceutically acceptable salt thereof. The invention addresses the object of providing a novel agent effective in the treatment of diseases caused by an RNA-containing virus belonging to the Enterovirus, Metapneumovirus, Pneumovirus, Respirovirus, or Alfa-coronavirus genus, and/or by a DNA-containing virus belonging to the Adenoviridae and/or Herpesviridae family, and in the prevention and treatment of asthma exacerbation, chronic obstructive pulmonary disease, mucoviscidosis, conjunctivitis, gastroenteritis, hepatitis, myocarditis; in the prevention and treatment of rhinorrhea, acute and infectious rhinitis, pharyngitis, nasopharyngitis, tonsillitis, laryngitis, laryngotracheitis, laryngotracheobronchitis, bronchitis, bronchiolitis, pneumonia, or airway obstructive syndrome.

Claim (Index 1):
A method for treating a disease in a patient, the method comprising administering to the patient a pharmaceutical composition comprising an effective amount of a compound having the following structure: or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or excipient, wherein the disease is caused by an RNA-containing virus belonging to the  Enterovirus, Metapneumovirus, Pneumovirus, Respirovirus , or  Alfa - coronavirus  genus, or by a DNA-containing virus belonging to the Adenoviridae or Herpesviridae family.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 96.0
- Lexical Diversity: 2.125
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15718274', '15718226', '15718295', '14783911', '15718252']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7929199688104638
- 35 USC 102 Novelty (BERT): 0.5283725909691709
- Combined Prediction Score: 0.7664652310263345
- Mean Citation Score: 350.796266
- Max Citation Score: 357.54947000000016
- Similarity Product: 286.6962548750293

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test